We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

AI drug discovery Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development EMA FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy

Unwrap our new Directory

http://Unwrap%20our%20new%20Directory

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

metastatic PDAC

Advertisement

cGxPJobs Banner

Phanes Therapeutics Shows Progress in PDAC with Spevatamig

San Diego, California, USA – April 22, 2026 In a significant development in oncology drug innovation, Phanes Therapeutics has...

By cGxPwire Editor
April 23, 2026

Read More

Advertisement

cGxPJobs

Recent Posts

01

Bio-Pharma

Bambusa Therapeutics Completes BBT001 Trial Enrollment
May 1, 2026
02

MedTech

SetPoint Medical Starts MS Study for Neuroimmune Therapy
May 1, 2026
03

Pharma

BeOne Medicines Gains FDA Priority Review for TEVIMBRA
May 1, 2026
04

Bio-Pharma

Kernal Biologics Showcases mRNA 2.0 CAR-T Platform
May 1, 2026
05

Pharma

Neurocrine Defines TDIS Threshold for TD Treatment Impact
May 1, 2026

Advertisement

Copyright © 2026 cGxP.wire | Made by 3styler

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Start typing and press Enter to search

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website